Wiemelt Knechtel

Life Science & FDA Regulatory Law

CONFIDENTIAL FREE INITIAL PHONE CONSULTATIONS nationwide by FDA regulatory attorneys of Wiemelt Knechtel, with offices in Chicago, Illinois (312-372-7664), Phoenix / Scottsdale, Arizona (602-910-4250), and SW Michigan (Coloma) (800-322-6562).  The FDA regulatory attorneys and trial lawyers of Wiemelt Knechtel offer a range of new drug, branded drug, generic drug, life science and pharmaceutical law services, including patent searches, non-provisional and provisional patent applications, opinions, transfers, licensing, pharma, FDA, ANDA, NDA, IND, 510(k), paragraph IV patent certifications, PMA, BLA, Hatch-Waxman and Orange Book representation, patent interferences, Lanham Act, false advertising, generic drug, and patent infringement litigation. Our Chicago, Phoenix / Scottsdale, Arizona, and SW Michigan-based law firm considers licensing and patent infringement matters on hybrid, contingent fee or contingency fee bases and provide a CONFIDENTIAL FREE INITIAL CONSULTATION.  Alternative billing arrangements, such as flat fee billing, flat rate billing, and hybrid billing, are also available for many matters.

Our firm was ranked among the "TOP PATENT FIRMS" in the U.S. in the March, 2010 issue of  Intellectual Property Today, a monthly publication focused on legal issues in patent, trademark and copyright law.  Our firm was also ranked among the "TOP TRADEMARK FIRMS" in the U.S. in the May, 2009, May 2010 and May, 2011 issues of Intellectual Property Today.

Our state-of-the-art computerized patent portfolio management software allows us to register, monitor, maintain, renew and protect our clients' patents worldwide.

Our technically trained and experienced IP litigators have unparalleled success in commercial and intellectual property litigation handling dozens of matters in Chicago, Michigan, Arizona, and worldwide for and against various Fortune 100 companies, including being lead counsel in lawsuits involving the intellectual property of such notables as Breckenridge Pharmaceutical, Inc., Albion Laboratories, Inc, J.C. Whitney & Co., Microsoft Corporation, Polo Ralph Lauren, Deston Therapeutics, L.L.C., PruGen, Inc., Rivers Edge Pharmaceuticals, L.L.C., Toll Brothers Homes, Inc., Sean John Clothing, Inc., Intel Corporation, AutoZone, Inc., PracticeWorks, Inc. (a Kodak company), Kellogg North America Company, International Truck and Engine Corporation (Navistar), CheckFree Corporation, United Brands Company, Inc., Americash Loans, LLC, Budget Rent A Car Corporation, American National Red Cross, Novartis Pharmaceuticals Corporation, Cibavision Corporation, Conseco, Inc., Windermere Holding, LLC, Thomas Kincade, Experian Information Solutions, Inc., Fusion Projects, LLC and Tampico Beverages.

TopTrademarkFirms2010.jpg

TopTrademarkFirms2010.jpg

FREE INITIAL CONSULTATION

IP AND LIFE SCIENCE LAWYERS WITH DEGREES IN MEDICINE AND ENGINEERING

CEASE AND DESIST LETTERS, PATENT INTERFERENCES, ORANGE BOOK LITIGATION AND INFRINGEMENT LITIGATION BY EXPERIENCED LITIGATORS

MEDICAL DEVICE PATENTS, BIOTECH AND PHARMACEUTICAL PATENTS BY EXPERIENCED M.D. AND REGISTERED PATENT ATTORNEYS

NEW DRUG, BRANDED DRUG AND GENERIC DRUG ADVICE AND LITIGATION

PATENT PORTFOLIO MANAGEMENT

CONFIDENTIAL PATENT SEARCHES AND APPLICATIONS

CONTINGENCY OR CONTINGENT FEE LITIGATION

IP INFRINGEMENT DEFENSE

TECHNOLOGY TRANSFER, ROYALTY NEGOTIATIONS AND LICENSING

  • Patentability Searches and Opinions by Experienced Patent Lawyers
  • Patent Infringement Opinions by Registered Patent Attorneys
  • Patent Validity and Enforceability Opinions
  • Patent Applications and Prosecution
  • Hourly and Contingent Infringement Litigation and Infringement Defense by Experienced IP Trial Lawyers and Appellate Attorneys
  • Patent Licensing Negotiation and Review
  • Orange Book Litigation
  • Insurance Policy Review
  • Representation before the United States Patent Office
  • Life Sciences, Pharmaceutical, Drug, Biometric and Biotech Patent Applications, Medical Device Applications, FDA, Hatch-Waxman, ANDA, NDA, Paragraph IV Patent Certification, New Drug, Branded Drug and Generic Drug Advice

© Copyright Wiemelt Knechtel, P.C. 2003-11. All rights reserved.